RxDoctor Payments DataLook up a doctor →

Jose Rivera-Acosta, MD

Gastroenterology · San Juan, PRNPI 1922201292

Payments from drug & device makers

$881,606in general payments, 2019–2025

Across 470 payments — averaging $1875.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intercept Pharmaceuticals, Inc.$322K
  • Pfizer$212K
  • Regeneron$137K
  • Madrigal Pharmaceuticals$88K
  • Boehringer Ingelheim International GmbH$79K
  • Eli Lilly Export S.A. Puerto Rico Branch$34K
  • plus $9K from 18 others
$2,042in research payments, 2019–2025

Across 2 payments — averaging $1021.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

What the payments were for

  • Food & beverage$6,746100%
  • Education$310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$881,606 in reported general payments places this provider in the 95th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$17,464
Medicare patients
54
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab12$83,995
XifaxanRifaximin11$36,361
Mesalamine DrMesalamine21$13,216
SuprepSodium, Potassium,mag Sulfates66$7,735
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates74$5,801
Sucralfate18$5,181
CholestyramineCholestyramine (With Sugar)26$3,518
Ursodiol36$2,791
Tacrolimus56$1,825
Colestipol Hcl15$1,730
Mycophenolate Mofetil23$1,417
Pantoprazole Sodium150$1,248
Lactulose15$860
Famotidine116$833
Clarithromycin14$760

Paid to pharmacies, not to this prescriber.

Other gastroenterology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →